[{"id":15877,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/alpx-2\/","name":"alpx-2","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2026\/03\/Image14.png","alt":""},"title":"ALPX","postMeta":[],"author":{"name":"araymond","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/araymond\/"},"date":"Mar 25, 2026","dateGMT":"2026-03-25 20:52:46","modifiedDate":"2026-03-31 11:40:58","modifiedDateGMT":"2026-03-31 15:40:58","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/2026\/\" rel=\"category tag\">2026<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/cro-cdmo\/\" rel=\"category tag\">CRO\/CDMO<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/services\/\" rel=\"category tag\">Services<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/2026\/\" rel=\"category tag\">2026<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/cro-cdmo\/\" rel=\"category tag\">CRO\/CDMO<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/services\/\" rel=\"category tag\">Services<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":22},"status":"publish","excerpt":"ALPX, an EMBL spin-off, provides comprehensive structural biology services to accelerate drug discovery programs. They specialize in delivering rapid and reliable structural insights for biotech and pharmaceutical partners, leveraging their expertise across X-ray crystallography, cryo-EM, and protein production."},{"id":16082,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/antineo\/","name":"antineo","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2026\/03\/Image7.png","alt":""},"title":"ANTINEO","postMeta":[],"author":{"name":"araymond","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/araymond\/"},"date":"Mar 25, 2026","dateGMT":"2026-03-25 20:52:10","modifiedDate":"2026-03-31 11:42:32","modifiedDateGMT":"2026-03-31 15:42:32","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/2026\/\" rel=\"category tag\">2026<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/cro-cdmo\/\" rel=\"category tag\">CRO\/CDMO<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/services\/\" rel=\"category tag\">Services<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/2026\/\" rel=\"category tag\">2026<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/cro-cdmo\/\" rel=\"category tag\">CRO\/CDMO<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/services\/\" rel=\"category tag\">Services<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":48},"status":"publish","excerpt":"Antineo is a Contract Research Organization (CRO) founded in May 2015, specialized in preclinical proof-of-concept studies for anticancer agents. Antineo\u2019s activity is based on providing services for the evaluation of new anticancer compounds (small molecules, antibodies, peptides, etc.). The company offers scientific consulting and supports its clients in optimizing the development of their anticancer candidates through a range of services covering in vitro assays (cell toxicity, sample characterization), ex vivo analyses (mechanism of action or target identification by flow cytometry), and in vivo studies (antitumor efficacy, toxicity, pharmacokinetics)."},{"id":16806,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/azurbio\/","name":"azurbio","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2026\/04\/Design-sans-titre-24.png","alt":""},"title":"AzurBio","postMeta":[],"author":{"name":"araymond","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/araymond\/"},"date":"Avr 16, 2026","dateGMT":"2026-04-16 13:27:08","modifiedDate":"2026-04-16 09:27:09","modifiedDateGMT":"2026-04-16 13:27:09","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/2026\/\" rel=\"category tag\">2026<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/services\/\" rel=\"category tag\">Services<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/2026\/\" rel=\"category tag\">2026<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/services\/\" rel=\"category tag\">Services<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":0,"sec":24},"status":"publish","excerpt":"AzurBio is the partner of choice for biopharma companies looking to launch their innovation in rare or serious diseases in the European market. With a dual presence in the US and Europe, we are supporting North American companies to access the EU market by maximizing flexibility and minimizing operational burden."},{"id":16466,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/chelatec-2\/","name":"chelatec-2","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2026\/03\/Image10-1.png","alt":""},"title":"Chelatec","postMeta":[],"author":{"name":"araymond","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/araymond\/"},"date":"Mar 27, 2026","dateGMT":"2026-03-27 15:31:00","modifiedDate":"2026-03-31 11:39:12","modifiedDateGMT":"2026-03-31 15:39:12","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/2026\/\" rel=\"category tag\">2026<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/cro-cdmo\/\" rel=\"category tag\">CRO\/CDMO<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/services\/\" rel=\"category tag\">Services<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/2026\/\" rel=\"category tag\">2026<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/cro-cdmo\/\" rel=\"category tag\">CRO\/CDMO<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/services\/\" rel=\"category tag\">Services<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":0,"sec":39},"status":"publish","excerpt":"Chelatec offers preclinical research services dedicated to the development of therapeutic radiopharmaceuticals in oncology. With state-of-the-art laboratories fully equipped for radiochemistry work, radioanalyses, handling of cells and housing of animals, Chelatec is recognized for its reliable expertise and proposes a unique combination of custom radiolabeling, in vitro assays and in vivo\/Ex vivo investigations capabilities."},{"id":16087,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/covalab-3\/","name":"covalab-3","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2026\/03\/Image23.png","alt":""},"title":"Covalab","postMeta":[],"author":{"name":"araymond","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/araymond\/"},"date":"Mar 25, 2026","dateGMT":"2026-03-25 20:51:47","modifiedDate":"2026-03-31 16:55:47","modifiedDateGMT":"2026-03-31 20:55:47","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/2026\/\" rel=\"category tag\">2026<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/services\/\" rel=\"category tag\">Services<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/2026\/\" rel=\"category tag\">2026<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/services\/\" rel=\"category tag\">Services<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":0,"sec":57},"status":"publish","excerpt":"Founded in 1995, Covalab is a French biotechnology company renowned for its expertise in antibody engineering. With over three decades of experience, Covalab specializes in the design and development of a wide range of antibodies, including polyclonal, monoclonal, scFv, FAb, VHH, and recombinant antibodies, utilizing advanced techniques such as DNA immunization."},{"id":16621,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/inpart-2\/","name":"inpart-2","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-37.png","alt":""},"title":"INPART","postMeta":[],"author":{"name":"araymond","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/araymond\/"},"date":"Avr 16, 2026","dateGMT":"2026-04-16 20:38:26","modifiedDate":"2026-04-16 16:38:27","modifiedDateGMT":"2026-04-16 20:38:27","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/2026\/\" rel=\"category tag\">2026<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/services\/\" rel=\"category tag\">Services<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/2026\/\" rel=\"category tag\">2026<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/services\/\" rel=\"category tag\">Services<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":1,"sec":17},"status":"publish","excerpt":"Inpart, the platform purpose-built for biopharma partnering and external innovation. Trusted by 500+ organizations across the life sciences ecosystem, including 70% of the world\u2019s top 50 pharmaceutical companies. Inpart helps life science teams discover and evaluate external innovation more effectively."},{"id":16083,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/owkin-2\/","name":"owkin-2","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-14.png","alt":""},"title":"Owkin","postMeta":[],"author":{"name":"araymond","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/araymond\/"},"date":"Mar 25, 2026","dateGMT":"2026-03-25 20:52:15","modifiedDate":"2026-03-31 16:54:30","modifiedDateGMT":"2026-03-31 20:54:30","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/2026\/\" rel=\"category tag\">2026<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/services\/\" rel=\"category tag\">Services<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/2026\/\" rel=\"category tag\">2026<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/biotech\/\" rel=\"category tag\">Biotech<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/services\/\" rel=\"category tag\">Services<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":0,"sec":39},"status":"publish","excerpt":"Owkin is an AI company on a mission to solve the complexity of biology. It is building the first Biological Artificial Super Intelligence (BASI) by combining powerful biological large language models, multimodal patient data, and agentic software. At the heart of this system is Owkin K, an AI copilot and its new LLM finetuned on biology called Owkin Zero, used by researchers, clinicians, and drug developers to better understand biology, validate scientific hypotheses, and deliver better diagnostics and therapies faster."},{"id":16080,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/phinc-development\/","name":"phinc-development","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2026\/03\/Image16.png","alt":""},"title":"Phinc Development","postMeta":[],"author":{"name":"araymond","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/araymond\/"},"date":"Mar 25, 2026","dateGMT":"2026-03-25 20:52:56","modifiedDate":"2026-04-08 14:59:54","modifiedDateGMT":"2026-04-08 18:59:54","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/2026\/\" rel=\"category tag\">2026<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/cro-cdmo\/\" rel=\"category tag\">CRO\/CDMO<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/services\/\" rel=\"category tag\">Services<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/2026\/\" rel=\"category tag\">2026<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/cro-cdmo\/\" rel=\"category tag\">CRO\/CDMO<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/services\/\" rel=\"category tag\">Services<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":0,"sec":57},"status":"publish","excerpt":"PhInc. Modeling is a Contract Research Organization (CRO) specialized in Quantitative Pharmacology Solutions to support biotechs in the development of drug candidates, new chemical and biological entities. We rely on the Model Informed Drug Development (MIDD) approach to make informed decisions supported by analyses and modeling."},{"id":15841,"link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/qima-life-sciences-2\/","name":"qima-life-sciences-2","thumbnail":{"url":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/wp-content\/uploads\/sites\/1378\/2024\/04\/Logos-site-BIO-2024-Entreprises-26.png","alt":""},"title":"QIMA Life Sciences","postMeta":[],"author":{"name":"araymond","link":"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/author\/araymond\/"},"date":"Mar 25, 2026","dateGMT":"2026-03-25 20:52:37","modifiedDate":"2026-03-31 15:54:55","modifiedDateGMT":"2026-03-31 19:54:55","commentCount":"0","commentStatus":"open","categories":{"coma":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/2026\/\" rel=\"category tag\">2026<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/cro-cdmo\/\" rel=\"category tag\">CRO\/CDMO<\/a>, <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/services\/\" rel=\"category tag\">Services<\/a>","space":"<a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/2026\/\" rel=\"category tag\">2026<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/cro-cdmo\/\" rel=\"category tag\">CRO\/CDMO<\/a> <a href=\"https:\/\/event.businessfrance.fr\/business-france-at-bio-convention\/category\/services\/\" rel=\"category tag\">Services<\/a>"},"taxonomies":{"post_tag":""},"readTime":{"min":0,"sec":34},"status":"publish","excerpt":"QIMA Life Sciences empowers global leaders in Pharmaceutical, Biotech, and Cosmetic industries with science-driven, predictive preclinical and clinical models & evaluations. Their solutions accelerate development, enhance success rates, and optimize resources by identifying the most promising candidates or active ingredients early in the pipeline. With deep scientific expertise, they serve as a trusted partner\u2014delivering robust data that strengthens decision-making and fuels innovation at every stage of product development\u2014because better science leads to better lives."}]